Skip to main content
Livermore
Livermore
ZHEN

Amneal Pharmaceuticals, Inc.

AMRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001723128

In the last 90 days, Amneal Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 3 sales; 311 institutions reported holding it in 13F filings for Q2 2026, worth $2.82B in total; no superinvestor holds it.

Q3 2024 vs. Q2 2024

How the institutions holding Amneal Pharmaceuticals, Inc. changed between Q2 2024 and Q3 2024.

All holders in Q3 2024All holders in Q2 2024

13F holders of AMRX: Q2 2024 compared with Q3 2024
MeasureQ2 2024Of which not filed for Q3 2024Q3 2024Change
Holders1821183+2
Shares138.7M11.3M142.7M+15.4M (+12.1%)
Value$880.5M$71.6M$1.19B+$378.8M (+46.8%)

1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (27)

Institutions that held Amneal Pharmaceuticals, Inc. at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to AMRX in Q3 2024
InstitutionSharesValue% of portfolio
BlackRock, Inc.12,410,552$103.3M0.00%
Walleye Capital LLC131,667$1.10M0.01%
Danske Bank A/S126,156$1.05M0.00%
Wellington Management Group LLP82,596$687.2K0.00%
Sherbrooke Park Advisers LLC66,567$553.8K0.13%
SG Americas Securities, LLC63,844$531.0K0.00%
Gotham Asset Management, LLC47,659$396.5K0.00%
Empirical Financial Services, LLC d.b.a. Empirical Wealth Management40,717$338.8K0.01%
Y-Intercept (Hong Kong) Ltd37,425$311.4K0.02%
Intech Investment Management LLC36,847$306.6K0.00%
Susquehanna International Group, LLP29,926$249.0K0.00%
Caxton Associates LP29,150$242.5K0.01%
Man Group plc27,529$229.0K0.00%
Aigen Investment Management, LP25,591$212.9K0.04%
Quadrature Capital Ltd20,336$169.2K0.00%
Dark Forest Capital Management LP14,135$117.6K0.02%
Fox Run Management, L.L.C.12,093$100.6K0.02%
Two Sigma Securities, LLC10,582$88.0K0.01%
Quest Partners LLC10,086$83.9K0.01%
Gladius Capital Management LP4,390$36.5K0.02%
Hemington Wealth Management340$2.00K0.00%
Sterling Capital Management LLC218$1.81K0.00%
Capital Performance Advisors LLP163$1.36K0.00%
Bessemer Group Inc160$1.00K0.00%
Picton Mahoney Asset Management133$1.00K0.00%
Federation des caisses Desjardins du Quebec100$8320.00%
National Bank of Canada2$170.00%

Sold out (25)

Institutions that held Amneal Pharmaceuticals, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.

Institutions that sold out of AMRX in Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
LSV Asset Management1,057,300$6.71M
Sanders Morris Harris LLC567,196$3.60M
Capula Management Ltd125,732$798.4K
Nebula Research & Development LLC119,284$757.5K
ExodusPoint Capital Management, LP111,969$711.0K
Thrivent Financial for Lutherans94,839$602.0K
D. E. Shaw & Co., Inc.89,895$570.8K
Tejara Capital Ltd86,824$551.3K
Norges Bank86,200$547.4K
CastleKnight Management LP64,100$407.0K
Centiva Capital, LP57,139$362.8K
Occudo Quantitative Strategies LP45,150$286.7K
Bank of Montreal36,078$238.8K
Dynamic Technology Lab Private Ltd35,843$227.0K
Omers Administration Corp27,200$172.7K
Public Employees Retirement System of Ohio24,510$155.6K
Corton Capital Inc.19,051$121.0K
Robeco Institutional Asset Management B.V.18,221$115.7K
Aquatic Capital Management LLC17,100$108.6K
Janney Montgomery Scott LLC11,960$76.0K
nVerses Capital, LLC9,800$62.2K
DekaBank Deutsche Girozentrale6,655$42.0K
Innealta Capital, LLC847$5.38K
Meeder Asset Management Inc442$2.81K
WR Wealth Planners, LLC59$375

Not filed for Q3 2024 yet (1)

Institutions that held Amneal Pharmaceuticals, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding AMRX in Q2 2024 that haven't filed for Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
BlackRock Inc.11,282,430$71.6M